Omnipod 5: Clinical Trials

7 trials of Omnipod 5, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

5 recruiting, 2 active not recruiting. 3 Not applicable.

By phase and status

PhaseTrialsStatus
Not applicable3Recruiting 3

Follow Omnipod 5: new trials by email Literature Review of Omnipod 5 trials Research Report on Omnipod 5

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
A Multi-centre Trial to Assess the Efficacy and Safety of the Omnipod 5 System in People With Type 2 Diabetes Undergoing Haemodialysis
Omnipod 5, Insulin injections - Type 2 Diabetes, Chronic Kidney Disease 5D
Not applicableRecruitingImperial College London842026-09-012026-10-19
The Impact of Early Automated Insulin Delivery (AID) Therapy on Diabetes Control and Comorbidities, and Cost-effectiveness of AID Treatment
Omnipod 5, Multiple daily injections of insulin - Type 1 Diabetes
Not applicableRecruitingHelsinki University Central Hospital1002026-08-152026-10-14
Omnipod-5 A French Prospective Multicentric Study in Real World (Optimal-B)
Omnipod 5 - Diabetes, Type 1 Diabetes
RecruitingInsulet Corporation1522026-03-162026-08-03
French Prospective Multicentric Study in Real World
Omnipod 5 - Diabetes, Diabetes Mellitus
Active not recruitingInsulet Corporation3042025-07-232026-08-03
Efficacy of Automated Insulin Therapy Early Initiated After Diagnosis on Blood Glucose Control in Children and Adolescents With Type 1 Diabetes
OmniPod 5, Dexcom G6, PAID questionnaires - Diabetes
Not applicableRecruitingUniversity Hospital, Montpellier1122024-05-292025-04-06
Post Market Registry for the Omnipod 5 System in Children and Adults With Type 1 Diabetes
Omnipod 5 - Type 1 Diabetes
RecruitingInsulet Corporation22002023-09-252026-07-01
The Impact of Hybrid Closed-loop Insulin Delivery in Type 1 Diabetes on Glycemic Control and PROMs
Medtronic MiniMed 670G, Medtronic MiniMed 780G, Tandem Control-IQ - Diabetes Mellitus, Type 1
Active not recruitingUniversitaire Ziekenhuizen KU Leuven16002020-03-122026-05-27

Conditions studied

Diabetes Mellitus, Type 1 (6)  ·  Diabetes Mellitus (3)  ·  Diabetes Mellitus, Type 2 (1)  ·  Renal Insufficiency, Chronic (1)

Sponsors

Insulet Corporation (3)  ·  Helsinki University Central Hospital (1)  ·  Imperial College London (1)  ·  Universitaire Ziekenhuizen KU Leuven (1)  ·  University Hospital, Montpellier (1)

Countries

France (3)  ·  Belgium (1)  ·  Finland (1)  ·  United Kingdom (1)  ·  United States (1)

Top investigators

Anna-Kaisa Tuomaala, MD, PhD (1)  ·  Jean-Pierre Riveline, MD, PhD (1)  ·  Mari-Anne Pulkkinen, MD, PhD (1)  ·  Pieter Gillard, MD (1)  ·  Tero Varimo, MD, PhD (1)

Results publications

PMID 38924290, PMID 39934368, PMID 40333328, PMID 41144887